Navigation Links
Delcath Systems, Inc. Announces Patient Recruitment Exceeds 90%
Date:8/25/2009

NEW YORK, Aug. 25 /PRNewswire-FirstCall/ -- Delcath Systems, Inc. (Nasdaq: DCTH), a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced today that it has exceeded 90% enrollment reaching 85 patients for its pivotal Phase III Metastatic Melanoma Trial. Based on trial specifications, the Company needs 92 for enrollment achievement.

"We are pleased to report this important patient enrollment milestone. Our success validates the need for a drug delivery platform that is unique in the interventional oncology arena. With approximately 250,000 cases of primary or secondary cancer of the liver diagnosed each year in the U.S. and 2.6 million cases globally, we believe our Percutaneous Hepatic Perfusion (PHP(TM)) technology is a compelling proposition," said Eamonn Hobbs, President and CEO of Delcath Systems. "Our next milestone will be a successful review of safety data in early September in preparation for a FDA submission by mid-2010, as well as CE Mark approval, which would allow for marketing outside the U.S.A. by June 2010."

About the Phase III Study

This clinical study is testing the Delcath PHP System(TM) for the regional delivery of melphalan to the liver to treat patients with metastatic cutaneous and ocular melanoma who have unresectable tumors in the liver. The Delcath PHP System(TM) is designed to deliver significantly higher doses of anti-cancer drugs to a patient's liver while minimizing entry of the drugs into the rest of the patient's circulation. This isolation limits toxicities which result from systemic chemotherapy treatments.

Patients in the Phase III trial are randomized into one of two treatment arms, including immediate treatment with melphalan via the Del
'/>"/>

SOURCE Delcath Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Delcath Systems Provides Update on Progress
2. Delcath Systems to Host July 27th Conference Call to Update Investors on Recent Progress
3. Delcath Systems to Host Quarterly Update Conference Call
4. Delcath Systems to Host Quarterly Update Conference Call
5. eMedical Systems, Inc. Selects MPMsoft as its Medical Billing Software Solution
6. Pitt researchers harness carbon nanomaterials for drug delivery systems, oxygen sensors
7. AdCare Health Systems, Inc. Continues To Be Profitable; Reports 2009 Second Quarter Earning Results
8. Enigma Diagnostics Announces Signing of Patent Licenses With Roche Molecular Systems, Inc.
9. OmniComm Systems, Inc. Retains Emerging Growth Equities, Ltd., as its Strategic Financial Advisor
10. Medical Data Systems, Inc. (MDS) Announces Operations Expansion and Opening of its Primary Collections Operations Office
11. Coapt Systems, Inc. Launches Hydrelle(TM) a New, FDA-Approved Dermal Filler with Lidocaine for Significant Wrinkle Correction and Greater Patient Comfort
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... 2014 As part of its ... LLP has been closely monitoring the ongoing meeting ... Obstetrics and Gynecology Devices Panel, which has ... cancer risks associated with the use of power ... a report published by Dow Jones Business News, ...
(Date:7/11/2014)... MA (PRWEB) July 11, 2014 ... at least $50 billion in fuel costs ... immediately. The current GHG standards ... have taken it upon themselves to install ... include: , 1.    Idle reduction technologies , 2.    Efficient ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 The ... Supplements, Specialty Nutrients, Animal Feed), Applications (Regular, Therapeutic, ... - Global Trends & Forecasts to 2019 ” ... an analysis and forecasting of the market value ... identifies the driving and restraining factors for the ...
(Date:7/11/2014)... 2014 Presently, disposable medical suppliers call ... and supplies segment. During the past two decades, the ... (on an average 12.5% per year), primarily owing to ... the US is the largest market for disposable medical ... 40%. The second position is held by Europe with ...
(Date:7/11/2014)... York, NY (PRWEB) July 11, 2014 ... during the five years to 2014 on the heels ... of 2010 prompted farmers to dedicate a larger share ... ethanol production. More specifically, the regulations required the mixing ... rapidly expanding biofuel production in the United States created ...
Breaking Medicine News(10 mins):Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Financial Ties Between FDA Advisory Panel Members and Manufacturers of Power Morcellators 2Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Financial Ties Between FDA Advisory Panel Members and Manufacturers of Power Morcellators 3Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Financial Ties Between FDA Advisory Panel Members and Manufacturers of Power Morcellators 4Health News:LeaseQ Agrees the Latest Round of Greenhouse Gas Rules Could Increase the Cost of Truck Acquisition and Maintenance 2Health News:LeaseQ Agrees the Latest Round of Greenhouse Gas Rules Could Increase the Cost of Truck Acquisition and Maintenance 3Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 2Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 3Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 4Health News:Probiotic Ingredient Market worth $1,732.8 Million by 2019 - A Report by MarketsandMarkets 5Health News:Global Disposable Medical Supplies Market to See Robust Growth Through Next Decade, According to New TriMark Report Available at MarketPublishers.com 2Health News:Global Disposable Medical Supplies Market to See Robust Growth Through Next Decade, According to New TriMark Report Available at MarketPublishers.com 3Health News:Corn Farming in Canada Industry Market Research Report Now Available From IBISWorld 2Health News:Corn Farming in Canada Industry Market Research Report Now Available From IBISWorld 3
... Continuing Education Lecture Series for Healthcare ... ... the,most common and most malignant type of glioma. Healthcare professionals,face many ... mean length of survival in patients is less than,one year., ...
... NORTH ANDOVER, Mass., March 24 Andover,Medical, Inc. (OTC ... medical equipment ("DME"), announced today that the,Company anticipates closing ... Complete terms of the financing can be,found in the ... 19, 2008 and,available at http://www.sec.gov ., On ...
... due to blocked arteries remains the leading cause of disease ... University College of Medicine researcher is helping to open new ... in the department of biomedical sciences, is researching mutant forms ... the human body grow new blood vessels to restore blood ...
... The Food Allergy &,Anaphylaxis Network (FAAN) will hold ... March 29, 2008. Many families struggle,with how best to ... living with food allergies for years or are dealing ... attendees will learn tips and strategies for living better,while ...
... activity among youth , , MONDAY, March 24 (HealthDay ... teen pregnancies without increasing levels of sexual intercourse ... researchers who reviewed data from a 2002 national ... 15 to 19. , There is ongoing debate ...
... Perrigo Company,(Nasdaq: PRGO ; TASE) today announced ... present at the 12th Annual Sidoti Emerging Growth,Institutional ... p.m. (ET) at the,Grand Hyatt Hotel in New ... global healthcare supplier that develops,manufactures and distributes over-the-counter ...
Cached Medicine News:Health News:Adult Glioblastoma: Strategies, Challenges, and Opportunities 2Health News:Andover Medical, Inc. Anticipates Closing $2.0 Million Private Financing 2Health News:Andover Medical, Inc. Anticipates Closing $2.0 Million Private Financing 3Health News:FSU researcher's 'mutant' proteins could lead to new treatment for heart disease 2Health News:FAAN Brings 'Food Allergies: Living and Learning' to Annual Food Allergy Conference in Baltimore 2Health News:FAAN Brings 'Food Allergies: Living and Learning' to Annual Food Allergy Conference in Baltimore 3Health News:Sex Ed Can Help Prevent Teen Pregnancy 2
(Date:7/11/2014)... CHAPEL HILL, N.C. , July 11, 2014 ... component of pharmaceutical marketing and, consequently, organizations are ... specifically for patients. As part of ... learned it,s important to educate, communicate and engage ... from disease awareness to patient empowerment. By mapping ...
(Date:7/11/2014)... DUBLIN , July 11, 2014 ... the "Global and Chinese Medical X-ray Film Industry ... http://photos.prnewswire.com/prnh/20130307/600769 Global And ... professional and in-depth study on the current state of ... on the Chinese situation. The report provides a ...
(Date:7/11/2014)... July 11, 2014  Kindred Hospital Houston Northwest, ... the opening of its new outpatient wound healing ... to people with chronic, hard to heal wounds. ... lead to amputation, lower leg wounds related to ... closure, and traumatic injury wounds which are complex ...
Breaking Medicine Technology:New Study Uses Six-Step Patient Journey as Framework for Consumer-Focused Marketing Opportunities 2Global and Chinese Medical X-ray Film Industry Report 2014 2Kindred Hospital Houston Northwest, With Wound Care Specialists, Opens Outpatient Wound Healing And Hyperbaric Center 2
... Feb. 17, 2011 Reportlinker.com announces that ... in its catalogue: Antivirals ... Combination Therapies to be Major Drivers HIV ... http://www.reportlinker.com/p0397049/Antivirals-Market-to-2016---Antiretroviral-Agents-and-Combination-Therapies-to-be-Major-Drivers-HIV-and-Hepatitis-C-Markets.html Antivirals Market ...
... Medical Devices, Inc. announced today that it has selected ... Schein Inc. (Nasdaq: HSIC ), the largest ... dental, medical and veterinary practitioners, as the exclusive distributor ... is the first and only surgical tourniquet single-use device ...
Cached Medicine Technology:Reportlinker Adds Antivirals Market to 2016 - Antiretroviral Agents and Combination Therapies to be Major Drivers HIV and Hepatitis C Markets 2Reportlinker Adds Antivirals Market to 2016 - Antiretroviral Agents and Combination Therapies to be Major Drivers HIV and Hepatitis C Markets 3OHK Medical Devices Selects Henry Schein as Exclusive Distributor of HemaClear® 2OHK Medical Devices Selects Henry Schein as Exclusive Distributor of HemaClear® 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: